What is Ajanta Pharma Ltd's PE ratio?

Ajanta Pharma Ltd trades at a P/E ratio of 37.30.

What is Ajanta Pharma Ltd's market cap?

Ajanta Pharma Ltd's market capitalisation is ₹42,097 Cr.

When are Ajanta Pharma Ltd's next results?

Ajanta Pharma Ltd's next earnings date is 30 Jul '26.

What is Ajanta Pharma Ltd's ROE?

Ajanta Pharma Ltd's return on equity (ROE) is 27.1%.

What sector is Ajanta Pharma Ltd in?

Ajanta Pharma Ltd (AJANTPHARM) is classified in the Healthcare sector (Pharmaceuticals).

Healthcare · Pharmaceuticals

Ajanta Pharma Ltd (AJANTPHARM)

₹3,369.50

Mkt cap

₹42,097 Cr

P/E ratio

37.30

P/B

9.31

Div yield

0.83%

ROE

27.10%

ROCE

34.50%

EPS (TTM)

₹90.34

Book value

₹362

52W range

2,388–3,575

Sector

Healthcare

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).

NSE AJANTPHARMBSE 532331www.ajantapharma.com

Health check

Constructive

ValuationFair

ProfitabilityStrong

GrowthModerate

TechnicalsBullish

52-week range

−5.76% from high

₹3,370

₹2,388+41.08% from low₹3,575

Current

₹3,369.50

Prev close

₹3,371.00

Day

−0.04%

Price performance

−0.04%

−2.87%

+5.95%

+21.85%

+25.53%

+20.93%

YTD

+14.25%

Financials

F

Revenue, profit & margin

P/E ratio

37.3×

AJANTPHARM is 10% above the sector median of 34.0×

AJANTPHARM37.3×

Sector median34.0×

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	882	1,021	1,028	1,105	1,054	1,145	1,187	1,146	1,170	1,303	1,354	1,375	1,422
Expenses	732	750	738	791	776	815	875	825	873	951	1,026	993	1,088
Operating Profit	149	271	291	314	278	330	311	321	297	351	328	382	333
OPM %	17%	27%	28%	28%	26%	29%	26%	28%	25%	27%	24%	28%	23%
Other Income	37	32	21	14	36	26	19	30	18	26	59	25	61
Interest	1	1	2	2	2	1	6	8	6	5	3	5	2
Depreciation	33	33	34	34	34	34	34	36	40	41	43	44	45
Profit before tax	152	269	276	291	278	322	290	307	269	331	341	359	347
Tax %	20%	23%	29%	28%	27%	24%	25%	24%	16%	23%	24%	24%	23%
Net Profit	122	208	195	210	203	246	216	233	225	255	260	274	267
EPS in Rs	9.54	16.24	15.24	16.39	15.82	19.68	17.33	18.64	18.03	20.44	20.83	21.91	21.35
Raw PDF

Earnings

EResults dates & reactions

Next results

30 Jul '26scheduled

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +1.69% · closed higher next day 43 of last 62

	Q1FY24	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25	Q4FY25	Q1FY26	Q2FY26	Q3FY26	Q4FY26
Broadcast	27 Jul '23◦	31 Oct '23◦	31 Jan '24◦	2 May '24◦	30 Jul '24◦	29 Oct '24	30 Jan '25◦	30 Apr '25◦	28 Jul '25	3 Nov '25	30 Jan '26	5 May '26
Earnings day	+4.07%	+3.65%	+0.32%	+6.71%	+6.50%	+0.06%	+0.66%	−4.47%	−0.62%	+3.01%	+3.23%	−0.11%
+1 day	+9.32%	+3.71%	−0.27%	+8.08%	+10.35%	+2.53%	+1.56%	−4.42%	+1.40%	+5.90%	+3.38%	+6.74%
+5 days	+12.52%	+2.16%	+1.32%	+6.42%	+16.16%	+6.61%	+0.82%	−6.22%	−5.32%	+4.56%	+5.86%	+6.58%
+15 days	+15.25%	+11.28%	−2.50%	+8.44%	+23.42%	+1.28%	−0.49%	−4.85%	−2.91%	+1.78%	+9.07%	+6.77%
+30 days	+11.33%	+7.62%	−2.39%	+6.47%	+34.01%	−3.94%	−3.74%	−2.66%	−6.84%	+5.31%	+9.62%	+6.16%
Filing	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	PDF	XBRL	XBRL	XBRL	XBRL

Corporate actions

CLast 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

Sas of Jun 2026

63.49%Promoter

Promoters63.49%2.76

FIIs7.68%0.58

DIIs21.80%3.44

Public7.03%0.11

Government0.00%0.01

Ownership trend

Peers

P8 companies

Valuation vs quality

P/E × ROCE · bubble = market cap

Name	CMP	P/E	Mkt Cap	Div Yld	NP Qtr	Qtr Profit Var	Sales Qtr	Qtr Sales Var	ROCE
Sun Pharma.Inds.	₹1,941.10	37.48	4,65,735	0.82%	2,710	+13.58%	14,612	+12.76%	20.53%
Divi's Lab.	₹7,248.50	73.36	1,92,425	0.41%	751	+13.44%	2,831	+9.52%	21.97%
Torrent Pharma.	₹4,961.50	86.11	1,88,720	0.77%	364	−20.58%	4,197	+41.84%	15.19%
Cipla	₹1,410.60	31.84	1,13,955	0.92%	786	−39.19%	7,119	+2.33%	15.49%
Zydus Lifesci.	₹1,108.70	20.38	1,10,593	0.09%	1,341	+21.92%	7,587	+16.22%	21.14%
Lupin	₹2,370.50	19.06	1,08,387	0.76%	1,469	+101.49%	7,475	+31.89%	29.93%
Mankind Pharma	₹2,507.20	51.44	1,03,546	0.04%	559	+34.23%	3,443	+11.81%	13.53%
Ajanta Pharma	₹3,369.50	37.30	42,097	0.83%	267	+18.40%	1,422	+21.47%	34.51%
Median: 157 Co.	₹432.05	34.03	1,978	0.10%	15	+28.10%	176	+17.66%	15.10%

Filings

D

Annual reports15

Financial Year 2026bse Financial Year 2025bse Financial Year 2024bse Financial Year 2023bse Financial Year 2022bse Financial Year 2021bse Financial Year 2020bse Financial Year 2019bse Financial Year 2018bse Financial Year 2017bse Financial Year 2016bse Financial Year 2015bse Financial Year 2014bse Financial Year 2013bse Financial Year 2012bse

Credit ratings6

Rating update 25 Aug 2025care Rating update 29 Aug 2024care Rating update 12 Sep 2023care Rating update 12 Sep 2022care Rating update 31 Aug 2021care Rating update 5 Oct 2020care

Announcements5

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 21 Jul - Ajanta Pharma will release Q1 FY2027 results and host an earnings call on 30 July 2026 at 4:15 p.m. IST.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 20 Jul Update on board meeting 20 Jul - Board meeting on 30 July 2026 to consider Q1 FY27 results and 1st interim dividend; record date 5 August 2026.Board Meeting Intimation for Board Meeting Scheduled To Be Held On 30Th July 2026. 20 Jul - Board meeting on 30 July 2026 to approve Q1 FY2027 standalone and consolidated results.Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 17 Jul - Ajanta Pharma held 47th AGM on 16 July 2026; voting results and interim dividend confirmation submitted.